Compositions for enhanced epithelial permeation of...

Details Compositions for enhanced epithelial permeation of... Compositions for enhanced epithelial permeation of...

2011-01-04

2011-01-04

Carlson, Karen Cochrane (Department: 1652)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C530S303000, C530S324000, C564S293000

Reexamination Certificate

active

07863245

ABSTRACT:
Pharmaceutical compositions comprising PYY(3-36) or Neuropeptide Y (NPY), a cyclodextrin, and a compound selected from phosphatidylcholine or diglyceride, wherein the PYY(3-36) or Neuropeptide Y (NPY) is present in an amount effective to alleviate one or more symptom(s) of obesity in a subject, and the cyclodextrin and the compound selected from phosphatidylcholine or diglyceride are present in an amount sufficient to enhance epithelial permeation.

REFERENCES:
patent: 5134127 (1992-07-01), Stella et al.
patent: 6046177 (2000-04-01), Stella et al.
patent: 6645774 (2003-11-01), Gerald
patent: 6667319 (2003-12-01), Stamford
patent: 6699891 (2004-03-01), Kawanishi
patent: 6890898 (2005-05-01), Bachovchin
patent: 7078381 (2006-07-01), Bachovchin
patent: 7157429 (2007-01-01), Bachovchin
patent: 7265125 (2007-09-01), Breu
patent: 7396809 (2008-07-01), Lu
patent: 2002/0197324 (2002-12-01), Watts et al.
patent: 2005/0176630 (2005-08-01), Cowley et al.
Nastech Pharmaceutical Company Clinical Trial Report 2008.

Affiliated with

Also associated with

Rating

Compositions for enhanced epithelial permeation of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compositions for enhanced epithelial permeation of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions for enhanced epithelial permeation of... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2714225